- YMAB Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Y-mAbs Therapeutics (YMAB) 8-K4 Jun 21Y-mAbs Announces Frontline Data for DANYELZA® (naxitamab-gqgk) in High-Risk NeuroblastomaFinancial data
Company Profile